Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7LL4
DownloadVisualize
BU of 7ll4 by Molmil
High-resolution crystal structure of human JAK2 kinase domain (JH1) bound to PN5-114.
Descriptor: Tyrosine-protein kinase JAK2, {1-(ethylsulfonyl)-3-[4-(2-{[3-fluoro-4-(1-methylpiperidin-4-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile
Authors:Karim, M.R, Schonbrunn, E.
Deposit date:2021-02-03
Release date:2022-01-12
Last modified:2023-11-15
Method:X-RAY DIFFRACTION (1.31 Å)
Cite:High-resolution crystal structure of human Janus Kinase 2 kinase domain (JH1) bound to PN5-114.
To Be Published
7LTY
DownloadVisualize
BU of 7lty by Molmil
Bruton's tyrosine kinase in complex with compound 23
Descriptor: DIMETHYL SULFOXIDE, Isoform BTK-C of Tyrosine-protein kinase BTK, ~{N}-[(5~{R})-2-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-6,7,8,9-tetrahydro-5~{H}-benzo[7]annulen-5-yl]-3-propan-2-yloxy-azetidine-1-carboxamide
Authors:Metrick, C.M, Marcotte, D.J.
Deposit date:2021-02-20
Release date:2022-01-12
Last modified:2023-10-18
Method:X-RAY DIFFRACTION (1.69 Å)
Cite:Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis.
J.Med.Chem., 65, 2022
7DU9
DownloadVisualize
BU of 7du9 by Molmil
Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib
Descriptor: Pralsetinib, Proto-oncogene tyrosine-protein kinase receptor Ret
Authors:Miyazaki, I, Ishida, K, Suzuki, T.
Deposit date:2021-01-08
Release date:2022-01-12
Last modified:2024-05-29
Method:X-RAY DIFFRACTION (2.31 Å)
Cite:Selective RET inhibitor TAS0953/HM06
To be published
7DUA
DownloadVisualize
BU of 7dua by Molmil
Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with 4-amino-7-(1-methylcyclopropyl)-N-(5-methyl-1H-pyrazol-3-yl)pyrrolo[2,3-d]pyrimidine-5-carboxamide
Descriptor: 4-azanyl-7-(1-methylcyclopropyl)-~{N}-(5-methyl-1~{H}-pyrazol-3-yl)pyrrolo[2,3-d]pyrimidine-5-carboxamide, Proto-oncogene tyrosine-protein kinase receptor Ret
Authors:Miyazaki, I, Ishida, K, Suzuki, T.
Deposit date:2021-01-08
Release date:2022-01-12
Last modified:2024-05-29
Method:X-RAY DIFFRACTION (1.64 Å)
Cite:Selective RET inhibitor TAS0953/HM06
To be published
7F3M
DownloadVisualize
BU of 7f3m by Molmil
Crystal structure of FGFR4 kinase domain with PRN1371
Descriptor: 6-[2,6-bis(chloranyl)-3,5-dimethoxy-phenyl]-2-(methylamino)-8-[3-(4-prop-2-enoylpiperazin-1-yl)propyl]pyrido[2,3-d]pyrimidin-7-one, Fibroblast growth factor receptor 4, SULFATE ION
Authors:Chen, X.J, Qu, L.Z, Dai, S.Y, Wei, H.D, Chen, Y.H.
Deposit date:2021-06-16
Release date:2022-01-12
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.289 Å)
Cite:Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors
Commun Chem, 5, 2022
7QHG
DownloadVisualize
BU of 7qhg by Molmil
LIM domain kinase 2 (LIMK2) in complex with TH-470
Descriptor: 1,2-ETHANEDIOL, 2-(2-methylpropanoylamino)-~{N}-[2-[(phenylmethyl)-[4-(phenylsulfamoyl)phenyl]carbonyl-amino]ethyl]-1,3-thiazole-5-carboxamide, LIM domain kinase 2
Authors:Mathea, S, Salah, E, Hanke, T, Knapp, S.
Deposit date:2021-12-12
Release date:2021-12-22
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (1.45 Å)
Cite:Development and Characterization of Type I, Type II, and Type III LIM-Kinase Chemical Probes.
J.Med.Chem., 65, 2022
7D5O
DownloadVisualize
BU of 7d5o by Molmil
C-Src in complex with TAS-120
Descriptor: 1-[(3S)-3-{4-amino-3-[(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}pyrrolidin-1-yl]prop-2-en-1-one, Proto-oncogene tyrosine-protein kinase Src
Authors:Qu, L.Z, Chen, Y.H.
Deposit date:2020-09-27
Release date:2021-12-22
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.69 Å)
Cite:Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors
Commun Chem, 5, 2022
7SZ0
DownloadVisualize
BU of 7sz0 by Molmil
Cryo-EM structure of the extracellular module of the full-length EGFR L834R bound to EGF. "tips-juxtaposed" conformation
Descriptor: Epidermal growth factor, Epidermal growth factor receptor
Authors:Huang, Y, Ognjenovic, J, Karandur, D, Miller, K, Merk, A, Subramaniam, S, Kuriyan, J.
Deposit date:2021-11-25
Release date:2021-12-22
Method:ELECTRON MICROSCOPY (3.3 Å)
Cite:A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor.
Elife, 10, 2021
7SZ1
DownloadVisualize
BU of 7sz1 by Molmil
Cryo-EM structure of the extracellular module of the full-length EGFR L834R bound to EGF. "tips-separated" conformation
Descriptor: Epidermal growth factor, Epidermal growth factor receptor
Authors:Huang, Y, Ognjenovic, J, Karandur, D, Miller, K, Merk, A, Subramaniam, S, Kuriyan, J.
Deposit date:2021-11-25
Release date:2021-12-22
Method:ELECTRON MICROSCOPY (3.4 Å)
Cite:A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor.
Elife, 10, 2021
7SZ5
DownloadVisualize
BU of 7sz5 by Molmil
Cryo-EM structure of the extracellular module of the full-length EGFR bound to TGF-alpha "tips-separated" conformation
Descriptor: Epidermal growth factor receptor, Transforming growth factor alpha
Authors:Huang, Y, Ognjenovic, J, Karandur, D, Miller, K, Merk, A, Subramaniam, S, Kuriyan, J.
Deposit date:2021-11-25
Release date:2021-12-22
Method:ELECTRON MICROSCOPY (3.6 Å)
Cite:A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor.
Elife, 10, 2021
7SYE
DownloadVisualize
BU of 7sye by Molmil
Cryo-EM structure of the extracellular module of the full-length EGFR bound to EGF. "tips-separated" conformation
Descriptor: Epidermal growth factor, Epidermal growth factor receptor
Authors:Huang, Y, Ognjenovic, J, Karandur, D, Miller, K, Merk, A, Subramaniam, S, Kuriyan, J.
Deposit date:2021-11-24
Release date:2021-12-22
Method:ELECTRON MICROSCOPY (3.3 Å)
Cite:A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor.
Elife, 10, 2021
7SYD
DownloadVisualize
BU of 7syd by Molmil
Cryo-EM structure of the extracellular module of the full-length EGFR bound to EGF "tips-juxtaposed" conformation
Descriptor: Epidermal growth factor, Epidermal growth factor receptor
Authors:Huang, Y, Ognjenovic, J, Karandur, D, Miller, K, Merk, A, Subramaniam, S, Kuriyan, J.
Deposit date:2021-11-24
Release date:2021-12-22
Method:ELECTRON MICROSCOPY (3.1 Å)
Cite:A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor.
Elife, 10, 2021
7SZ7
DownloadVisualize
BU of 7sz7 by Molmil
Cryo-EM structure of the extracellular module of the full-length EGFR bound to TGF-alpha. "tips-juxtaposed" conformation
Descriptor: Epidermal growth factor receptor, Transforming growth factor alpha
Authors:Huang, Y, Ognjenovic, J, Karandur, D, Miller, K, Merk, A, Subramaniam, S, Kuriyan, J.
Deposit date:2021-11-25
Release date:2021-12-15
Method:ELECTRON MICROSCOPY (3.4 Å)
Cite:A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor.
Elife, 10, 2021
7OZF
DownloadVisualize
BU of 7ozf by Molmil
FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 19.
Descriptor: 1,2-ETHANEDIOL, CHLORIDE ION, Fibroblast growth factor receptor 1, ...
Authors:Trinh, C.H, Turner, L.D, Fishwick, C.W.G.
Deposit date:2021-06-28
Release date:2021-12-01
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (1.82 Å)
Cite:From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor.
J.Med.Chem., 65, 2022
7OZB
DownloadVisualize
BU of 7ozb by Molmil
FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 38.
Descriptor: 1,2-ETHANEDIOL, 4-[3-(4-piperazin-4-ium-1-ylphenyl)-1H-indazol-6-yl]phenol, Fibroblast growth factor receptor 1, ...
Authors:Trinh, C.H, Turner, L.D, Fishwick, C.W.G.
Deposit date:2021-06-27
Release date:2021-12-01
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (1.71 Å)
Cite:From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor.
J.Med.Chem., 65, 2022
7OZY
DownloadVisualize
BU of 7ozy by Molmil
FGFR2 kinase domain (residues 461-763) in complex with 38.
Descriptor: 1,2-ETHANEDIOL, 4-[3-(4-piperazin-4-ium-1-ylphenyl)-1H-indazol-6-yl]phenol, Fibroblast growth factor receptor 2, ...
Authors:Trinh, C.H, Turner, L.D, Fishwick, C.W.G.
Deposit date:2021-06-29
Release date:2021-12-01
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (2.28 Å)
Cite:From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor.
J.Med.Chem., 65, 2022
7OZD
DownloadVisualize
BU of 7ozd by Molmil
FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 34.
Descriptor: 1,2-ETHANEDIOL, Fibroblast growth factor receptor 1, N-[6-(4-hydroxyphenyl)-1H-indazol-3-yl]benzamide, ...
Authors:Trinh, C.H, Turner, L.D, Fishwick, C.W.G.
Deposit date:2021-06-27
Release date:2021-12-01
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (1.82 Å)
Cite:From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor.
J.Med.Chem., 65, 2022
7MFC
DownloadVisualize
BU of 7mfc by Molmil
Crystal structure of CSF1R in complex with vimseltinib
Descriptor: Macrophage colony-stimulating factor 1 receptor, Vimseltinib
Authors:Abendroth, J, Davies, D.R, Atkins, K.
Deposit date:2021-04-08
Release date:2021-11-24
Last modified:2023-10-18
Method:X-RAY DIFFRACTION (2.8 Å)
Cite:Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages.
Mol.Cancer Ther., 20, 2021
7MON
DownloadVisualize
BU of 7mon by Molmil
Structure of human RIPK3-MLKL complex
Descriptor: Mixed lineage kinase domain-like protein, N-[4-({2-[(cyclopropanecarbonyl)amino]pyridin-4-yl}oxy)-3-fluorophenyl]-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide, Receptor-interacting serine/threonine-protein kinase 3
Authors:Meng, Y, Davies, K.A, Czabotar, P.E, Murphy, J.M.
Deposit date:2021-05-03
Release date:2021-11-17
Last modified:2023-10-18
Method:X-RAY DIFFRACTION (2.23 Å)
Cite:Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis.
Nat Commun, 12, 2021
7MGK
DownloadVisualize
BU of 7mgk by Molmil
TNNI3K complexed with 1-(3,5-dichloro-4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)-3-(3-(trifluoromethyl)phenyl)urea
Descriptor: N-(3,5-dichloro-4-{[6-(methylamino)pyrimidin-4-yl]oxy}phenyl)-N'-[3-(trifluoromethyl)phenyl]urea, Serine/threonine-protein kinase TNNI3K
Authors:Shewchuk, L.M.
Deposit date:2021-04-12
Release date:2021-11-10
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (3.1 Å)
Cite:Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38 alpha , and B-Raf.
J.Med.Chem., 64, 2021
7MN8
DownloadVisualize
BU of 7mn8 by Molmil
Structure of the HER2/HER3/NRG1b Heterodimer Extracellular Domain bound to Trastuzumab Fab
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Isoform 6 of Pro-neuregulin-1, ...
Authors:Diwanji, D, Trenker, R, Verba, K.A, Jura, N.
Deposit date:2021-04-30
Release date:2021-11-10
Last modified:2021-12-22
Method:ELECTRON MICROSCOPY (3.45 Å)
Cite:Structures of the HER2-HER3-NRG1 beta complex reveal a dynamic dimer interface.
Nature, 600, 2021
7MGJ
DownloadVisualize
BU of 7mgj by Molmil
TNNI3K complexed with N-methyl-4-(4-(3-(3-(trifluoromethyl) phenyl) ureido) phenoxy)picolinamide
Descriptor: N-methyl-4-[4-({[3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]pyridine-2-carboxamide, Serine/threonine-protein kinase TNNI3K
Authors:Shewchuk, L.M.
Deposit date:2021-04-12
Release date:2021-11-10
Last modified:2024-04-03
Method:X-RAY DIFFRACTION (2.95 Å)
Cite:Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38 alpha , and B-Raf.
J.Med.Chem., 64, 2021
7RN6
DownloadVisualize
BU of 7rn6 by Molmil
High-resolution crystal structure of human JAK2 kinase domain (JH1) bound to type-II inhibitor BBT594
Descriptor: 1,2-ETHANEDIOL, 5-{[6-(acetylamino)pyrimidin-4-yl]oxy}-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-2,3-dihydro-1H-indole-1-carboxamide, Tyrosine-protein kinase JAK2
Authors:Karim, M.R, Schonbrunn, E.
Deposit date:2021-07-29
Release date:2021-11-03
Last modified:2023-11-15
Method:X-RAY DIFFRACTION (1.5 Å)
Cite:High-resolution crystal structure of human JAK2 kinase domain (JH1) bound to type-II inhibitor BBT594
To Be Published
7P3V
DownloadVisualize
BU of 7p3v by Molmil
B-Raf V600E structure bound to a new inhibitor
Descriptor: Serine/threonine-protein kinase B-raf, ~{N}-[3-[5-(2-azanylpyrimidin-4-yl)-2-[(3~{S})-morpholin-3-yl]-1,3-thiazol-4-yl]-2-fluoranyl-phenyl]-2,5-bis(fluoranyl)benzenesulfonamide
Authors:Schneider, M, Gelin, M, Cohen-Gonsaud, M, Labesse, G.
Deposit date:2021-07-08
Release date:2021-11-03
Last modified:2024-01-31
Method:X-RAY DIFFRACTION (2.37 Å)
Cite:Structure-Based and Knowledge-Informed Design of B-Raf Inhibitors Devoid of Deleterious PXR Binding.
J.Med.Chem., 65, 2022
7MN5
DownloadVisualize
BU of 7mn5 by Molmil
Structure of the HER2/HER3/NRG1b Heterodimer Extracellular Domain
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Isoform 6 of Pro-neuregulin-1, ...
Authors:Diwanji, D, Trenker, R, Verba, K.A, Jura, N.
Deposit date:2021-04-30
Release date:2021-10-27
Last modified:2021-12-22
Method:ELECTRON MICROSCOPY (2.93 Å)
Cite:Structures of the HER2-HER3-NRG1 beta complex reveal a dynamic dimer interface.
Nature, 600, 2021

220472

PDB entries from 2024-05-29

PDB statisticsPDBj update infoContact PDBjnumon